News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,793 Results
Type
Article (86538)
Company Profile (702)
Press Release (760553)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232705)
Career Advice (4128)
Deals (39722)
Drug Delivery (129)
Drug Development (90994)
Employer Resources (198)
FDA (18114)
Job Trends (17341)
News (396506)
Policy (39757)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56842)
ALS (107)
Alzheimer's disease (1509)
Antibody-drug conjugate (ADC) (165)
Approvals (18071)
Artificial intelligence (340)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (87)
Brain cancer (32)
Breast cancer (318)
Cancer (2515)
Cardiovascular disease (212)
Career advice (3535)
Career pathing (34)
CAR-T (182)
Cell therapy (512)
Cervical cancer (22)
Clinical research (73523)
Collaboration (942)
Company closure (2)
Compensation (593)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (279)
Cystic fibrosis (110)
Data (2422)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (303)
Diagnostics (6937)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (154)
Drug pricing (136)
Drug shortages (33)
Duchenne muscular dystrophy (106)
Earnings (97197)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130342)
Executive appointments (798)
FDA (19579)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (847)
Gene editing (125)
Generative AI (36)
Gene therapy (377)
GLP-1 (867)
Government (5179)
Grass and pollen (6)
Guidances (169)
Healthcare (20893)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (157)
Indications (30)
Infectious disease (3034)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (104)
Interviews (813)
IPO (17840)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10115)
Liver cancer (82)
Lung cancer (352)
Lymphoma (164)
Machine learning (9)
Management (65)
Manufacturing (381)
MASH (86)
Medical device (14651)
Medtech (14656)
Mergers & acquisitions (22463)
Metabolic disorders (818)
Multiple sclerosis (90)
NASH (23)
Neurodegenerative disease (121)
Neuropsychiatric disorders (35)
Neuroscience (2146)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (436)
Opinion (276)
Ovarian cancer (84)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (167)
Partnered (25)
Patents (262)
Patient recruitment (120)
Peanut (51)
People (65365)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22693)
Phase II (31928)
Phase III (24044)
Pipeline (1485)
Policy (183)
Postmarket research (3552)
Preclinical (10246)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (441)
Real estate (7392)
Recruiting (75)
Regulatory (26851)
Reports (59)
Research institute (2659)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (5)
RSV (50)
Schizophrenia (84)
Series A (146)
Series B (98)
Service/supplier (30)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (58)
The Weekly (84)
Vaccines (826)
Venture capitalists (45)
Weight loss (308)
Women's health (41)
Worklife (20)
Date
Today (212)
Last 7 days (975)
Last 30 days (3592)
Last 365 days (35563)
2025 (13332)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50185)
Australia (8840)
California (6805)
Canada (2126)
China (583)
Colorado (293)
Connecticut (311)
Delaware (171)
Europe (115192)
Florida (994)
Georgia (231)
Hawaii (1)
Idaho (64)
Illinois (646)
India (31)
Indiana (348)
Iowa (12)
Japan (180)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (71)
Maryland (1001)
Massachusetts (5200)
Michigan (255)
Minnesota (437)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (70)
New Hampshire (70)
New Jersey (1899)
New Mexico (31)
New York (1908)
North Carolina (1158)
North Dakota (9)
Northern California (2947)
Ohio (226)
Oklahoma (15)
Oregon (48)
Pennsylvania (1487)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (27)
South Dakota (1)
Southern California (2520)
Tennessee (110)
Texas (1023)
United States (25922)
Utah (199)
Virginia (180)
Washington D.C. (72)
Washington State (624)
West Virginia (3)
Wisconsin (74)
There are 847,793 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
GSK, iTeos Abandon TIGIT Therapy, Adding to Long List of Recent Class Failures
Belrestotug showed underwhelming efficacy outcomes in mid-stage studies of non-small cell lung cancer and head and neck squamous cell carcinoma.
May 14, 2025
·
2 min read
·
Tristan Manalac
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.
May 14, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Bayer, Leap, Atara Reduce Workforces Amid Strategic Reorganizations
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 14, 2025
·
203 min read
·
BioSpace Editorial Staff
Press Releases
Three Finalists Announced for the 2025 Bloom Burton Award
Recognizing the Year’s Most Significant Contributions to Canada’s Innovative Healthcare Industry
May 14, 2025
·
1 min read
Press Releases
PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
May 14, 2025
·
2 min read
Press Releases
Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments
May 14, 2025
·
3 min read
Press Releases
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
May 14, 2025
·
7 min read
Podcast
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price negotiations; Vinay Prasad to take the helm at the FDA’s Center for Biologics Evaluation and Research; Bayer cuts 2,000 more employees; Eli Lilly’s Zepbound scores again; and the Galapagos story turns again.
May 14, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025
May 14, 2025
·
3 min read
1 of 84,780
Next
